318 related articles for article (PubMed ID: 31679431)
21. Expressions of TOLL-like receptor 4 (TLR-4) and matrix metalloproteinase 9 (MMP-9)/Tissue inhibitor of metalloproteinase 1 (TIMP-1) in pulmonary blood vessels with chronic obstructive pulmonary diseases and their relationships with pulmonary vascular remodelling.
Yu WC; Cong JP; Mi LY
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):361-367. PubMed ID: 30133616
[TBL] [Abstract][Full Text] [Related]
22. [The role of matrix metalloproteinases in extracellular matrix remodelling in chronic obstructive pulmonary disease rat models].
Li H; Cui D; Tong X; Ma N; Gao Y; Cui X; Lu L; Wang D; Liang Y
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):393-8. PubMed ID: 12137602
[TBL] [Abstract][Full Text] [Related]
23. Relationship between expression of matrix metalloproteinase-9 and adenylyl cyclase-associated protein 1 in chronic obstructive pulmonary disease.
Xie SS; Hu F; Tan M; Duan YX; Song XL; Wang CH
J Int Med Res; 2014 Dec; 42(6):1272-84. PubMed ID: 25332229
[TBL] [Abstract][Full Text] [Related]
24. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
[TBL] [Abstract][Full Text] [Related]
25. Fengbaisan suppresses endoplasmic reticulum stress by up-regulating SIRT1 expression to protect rats with chronic obstructive pulmonary diseases.
Wang Y; Su NX; Pan SG; Ge XP; Dai XP
Pharm Biol; 2020 Dec; 58(1):878-885. PubMed ID: 32897804
[TBL] [Abstract][Full Text] [Related]
26. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
Li L; Liu Y; Li J; Gao JM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
[No Abstract] [Full Text] [Related]
27. The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity.
Dimic-Janjic S; Hoda MA; Milenkovic B; Kotur-Stevuljevic J; Stjepanovic M; Gompelmann D; Jankovic J; Miljkovic M; Milin-Lazovic J; Djurdjevic N; Maric D; Milivojevic I; Popevic S
Eur J Med Res; 2023 Mar; 28(1):127. PubMed ID: 36935521
[TBL] [Abstract][Full Text] [Related]
28. STAT4 activation in smokers and patients with chronic obstructive pulmonary disease.
Di Stefano A; Caramori G; Capelli A; Gnemmi I; Ricciardolo FL; Oates T; Donner CF; Chung KF; Barnes PJ; Adcock IM
Eur Respir J; 2004 Jul; 24(1):78-85. PubMed ID: 15293608
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
Hao W; Li M; Zhang C; Zhang Y; Wang P
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
[No Abstract] [Full Text] [Related]
30. Effects of Fengbaisan on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in lung tissue of rats with chronic obstructive pulmonary disease.
Wang Y; Su NX; Chen ZQ; Wang Z; Zhang SF
Chin J Integr Med; 2014 Mar; 20(3):224-31. PubMed ID: 24242136
[TBL] [Abstract][Full Text] [Related]
31. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
Xu XM; Sun TY; Lin JB; Zhang HS
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
[TBL] [Abstract][Full Text] [Related]
32. Effect of Liuweibuqi Capsules in Pulmonary Alveolar Epithelial Cells and COPD Through JAK/STAT Pathway.
Wang C; Ding H; Tang X; Li Z; Gan L
Cell Physiol Biochem; 2017; 43(2):743-756. PubMed ID: 28950251
[TBL] [Abstract][Full Text] [Related]
33. Serum metalloproteinase-9 is related to COPD severity and symptoms - cross-sectional data from a population based cohort-study.
Linder R; Rönmark E; Pourazar J; Behndig A; Blomberg A; Lindberg A
Respir Res; 2015 Feb; 16(1):28. PubMed ID: 25849664
[TBL] [Abstract][Full Text] [Related]
34. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
[TBL] [Abstract][Full Text] [Related]
35. Increased serum concentrations of tissue inhibitor of metalloproteinase-1 in COPD patients.
Higashimoto Y; Yamagata Y; Iwata T; Okada M; Ishiguchi T; Sato H; Masuda M; Itoh H
Eur Respir J; 2005 May; 25(5):885-90. PubMed ID: 15863647
[TBL] [Abstract][Full Text] [Related]
36. Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow.
Kang MJ; Oh YM; Lee JC; Kim DG; Park MJ; Lee MG; Hyun IG; Han SK; Shim YS; Jung KS
J Korean Med Sci; 2003 Dec; 18(6):821-7. PubMed ID: 14676438
[TBL] [Abstract][Full Text] [Related]
37. [Effect of Krüppel like zinc finger transcription factor 2 on γ-glutamylcysteine synthetase in bronchial epithelial cells of chronic obstructive pulmonary disease].
Li J; Dai AG; Huang CY; Hu RC
Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):112-118. PubMed ID: 28088955
[No Abstract] [Full Text] [Related]
38. Changes and clinical significance of serum MMP-9, TIMP-1, COX-2, and immune levels in patients with asthma.
Ming H; Huang Y; Mao J; Wang H; Gao X; Li Z
Allergol Immunopathol (Madr); 2023; 51(6):83-88. PubMed ID: 37937500
[TBL] [Abstract][Full Text] [Related]
39. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
[TBL] [Abstract][Full Text] [Related]
40. A2M Serves as Promising Biomarker for Chronic Obstructive Pulmonary Disease.
Xiao X; Cai W; Ding Z; Shi Y; Fan L; Zhang Q
Int J Chron Obstruct Pulmon Dis; 2023; 18():683-692. PubMed ID: 37123074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]